Literature DB >> 18459149

Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Jessica Plati1, Octavian Bucur, Roya Khosravi-Far.   

Abstract

Apoptosis is a tightly regulated cell suicide program that plays an essential role in the maintenance of tissue homeostasis by eliminating unnecessary or harmful cells. Defects in this native defense mechanism promote malignant transformation and frequently confer chemoresistance to transformed cells. Indeed, the evasion of apoptosis has been recognized as a hallmark of cancer. Given that multiple mechanisms function at many levels to orchestrate the regulation of apoptosis, a multitude of opportunities for apoptotic dysregulation are present within the intricate signaling network of cell. Several of the molecular mechanisms by which cancer cells are protected from apoptosis have been elucidated. These advances have facilitated the development of novel apoptosis-inducing agents that have demonstrated single-agent activity against various types of cancers cells and/or sensitized resistant cancer cells to conventional cytotoxic therapies. Herein, we will highlight several of the central modes of apoptotic dysregulation found in cancer. We will also discuss several therapeutic strategies that aim to reestablish the apoptotic response, and thereby eradicate cancer cells, including those that demonstrate resistance to traditional therapies. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459149      PMCID: PMC2941905          DOI: 10.1002/jcb.21707

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  268 in total

1.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

Review 2.  Apoptosome dysfunction in human cancer.

Authors:  K M Hajra; J R Liu
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

3.  Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.

Authors:  Y Kitagawa; F Wong; P Lo; M Elliott; L M Verburgt; J C Hogg; M Daya
Journal:  Am J Respir Cell Mol Biol       Date:  1996-07       Impact factor: 6.914

4.  Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

Authors:  I Tamm; S M Kornblau; H Segall; S Krajewski; K Welsh; S Kitada; D A Scudiero; G Tudor; Y H Qui; A Monks; M Andreeff; J C Reed
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

5.  U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.

Authors:  Martin H Cohen; John R Johnson; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

6.  Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.

Authors:  Charles Erlichman; Manuel Hidalgo; Joseph P Boni; Patricia Martins; Susan E Quinn; Charles Zacharchuk; Peter Amorusi; Alex A Adjei; Eric K Rowinsky
Journal:  J Clin Oncol       Date:  2006-05-20       Impact factor: 44.544

Review 7.  Cellular stress response and apoptosis in cancer therapy.

Authors:  I Herr; K M Debatin
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

Review 8.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.

Authors:  Heath A Elrod; Yi-Dan Lin; Ping Yue; Xuerong Wang; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2007-06-29       Impact factor: 6.261

10.  Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.

Authors:  Haiying Sun; Zaneta Nikolovska-Coleska; Chao-Yie Yang; Liang Xu; York Tomita; Krzysztof Krajewski; Peter P Roller; Shaomeng Wang
Journal:  J Med Chem       Date:  2004-08-12       Impact factor: 7.446

View more
  72 in total

1.  Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer.

Authors:  Rajendra Karki; Bhesh Raj Sharma; Ein Lee; Balaji Banoth; R K Subbarao Malireddi; Parimal Samir; Shraddha Tuladhar; Harisankeerth Mummareddy; Amanda R Burton; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

3.  Thromboxane A2 modulates cisplatin-induced apoptosis through a Siva1-dependent mechanism.

Authors:  C Iorio-Morin; P Germain; S Roy; S Génier; P Labrecque; J-L Parent
Journal:  Cell Death Differ       Date:  2012-02-17       Impact factor: 15.828

4.  Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis.

Authors:  Derek J MacPherson; Caitlyn L Mills; Mary Jo Ondrechen; Jeanne A Hardy
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

5.  Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.

Authors:  Gholamreza Khamisipour; Elham Mansourabadi; Behrouz Naeimi; Ali Moazzeni; Rahim Tahmasebi; Mojtaba Hasanpour; Majid Mosahebi Mohammadi; Zahra Mansourabadi; Shakib Shamsian
Journal:  Mol Clin Oncol       Date:  2017-12-08

6.  Phosphorylation of the transcription factor YY1 by CK2α prevents cleavage by caspase 7 during apoptosis.

Authors:  Sarah Riman; Raed Rizkallah; Ari Kassardjian; Karen E Alexander; Bernhard Lüscher; Myra M Hurt
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

7.  Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction.

Authors:  Jessica Gliozzo; Paolo Perlasca; Marco Mesiti; Elena Casiraghi; Viviana Vallacchi; Elisabetta Vergani; Marco Frasca; Giuliano Grossi; Alessandro Petrini; Matteo Re; Alberto Paccanaro; Giorgio Valentini
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

8.  Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms.

Authors:  Scott J Eron; Kishore Raghupathi; Jeanne A Hardy
Journal:  Structure       Date:  2016-11-23       Impact factor: 5.006

9.  Molecular alterations associated with chronic exposure to cigarette smoke and chewing tobacco in normal oral keratinocytes.

Authors:  Pavithra Rajagopalan; Krishna Patel; Ankit P Jain; Vishalakshi Nanjappa; Keshava K Datta; Tejaswini Subbannayya; Kiran K Mangalaparthi; Anjali Kumari; Malini Manoharan; Karunakaran Coral; Sakthivel Murugan; Bipin Nair; T S Keshava Prasad; Premendu P Mathur; Ravi Gupta; Rohit Gupta; Arati Khanna-Gupta; Joseph Califano; David Sidransky; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2018-05-29       Impact factor: 4.742

10.  Pre-Treatment of Pterostilbene Enhances H2O2-induced Cell Apoptosis Through Caspase-dependent Pathway in Human Keratinocyte Cells.

Authors:  Yu-Cheng Chou; Shu-Fen Peng; Yi-Ching Cheng; Po-Yuan Chen; Tzong-DER Way; Ching-Ling Cheng; Yi-Ping Huang; Te-Chun Hsia
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.